Patents by Inventor Tanja Ligensa

Tanja Ligensa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IGF-1 RECEPTOR INTERACTING PROTEINS
    Publication number: 20090018312
    Abstract: The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and its use in diagnosis and therapy. This nucleic acid molecule (IIP-10) is a gene which encodes an IGF-1 receptor binding polypeptide.
    Type: Application
    Filed: September 13, 2007
    Publication date: January 15, 2009
    Inventors: Tanja Ligensa, Ralf Schumacher, Michael Weidner
  • Methods for detecting cancer cells by using nucleic acid encoding for IGF-1 receptor interacting proteins
    Patent number: 7348165
    Abstract: The invention relates generally to a method for the detection of the proliferation of a tumor cell and more specifically wherein said method comprises nucleic acids (SEQ ID NO:1) encoding IIP-1.
    Type: Grant
    Filed: May 12, 2004
    Date of Patent: March 25, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Tanja Ligensa, Ralf Schumacher, Michael Weidner
  • IGF-1 receptor interacting proteins
    Patent number: 7329734
    Abstract: The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and its use in diagnosis and therapy. This nucleic acid molecule (IIP-10) is a gene which encodes an IGF-1 receptor binding polypeptide.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: February 12, 2008
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Tanja Ligensa, Ralf Schumacher, Michael Weidner
  • IGF-1 receptor interacting proteins
    Patent number: 7202058
    Abstract: The invention comprises a method of screening compound(s) that inhibit the interaction between IGF-1R and IIP-10.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: April 10, 2007
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Tanja Ligensa, Ralf Schumacher, Michael Weidner
  • IGF-1 receptor interacting proteins
    Publication number: 20060040358
    Abstract: The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and its use in diagnosis and therapy. This nucleic acid molecule (IIP-10) is a gene which encodes an IGF-1 receptor binding polypeptide.
    Type: Application
    Filed: October 18, 2005
    Publication date: February 23, 2006
    Inventors: Tanja Ligensa, Ralf Schumacher, Michael Weidner
  • IGF-1 receptor interacting proteins
    Patent number: 6913883
    Abstract: The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and its use in diagnosis and therapy. This nucleic acid molecule (IIP-10) is a gene which encodes an IGF-1 receptor binding polypeptide.
    Type: Grant
    Filed: July 30, 2001
    Date of Patent: July 5, 2005
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Tanja Ligensa, Ralf Schumacher, Michael Weidner
  • IGF-1 receptor interacting proteins
    Publication number: 20050019832
    Abstract: The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and its use in diagnosis and therapy. This nucleic acid molecule (IIP-10) is a gene which encodes an IGF-1 receptor binding polypeptide.
    Type: Application
    Filed: June 14, 2004
    Publication date: January 27, 2005
    Inventors: Tanja Ligensa, Ralf Schumacher, Michael Weidner
  • IGF-1 receptor interacting proteins
    Publication number: 20040225114
    Abstract: The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and its use in diagnosis and therapy. This nucleic acid molecule (IIP-10) is a gene which encodes an IGF-1 receptor binding polypeptide.
    Type: Application
    Filed: June 14, 2004
    Publication date: November 11, 2004
    Inventors: Tanja Ligensa, Ralf Schumacher, Michael Weidner
  • IGF-1 receptor interacting proteins
    Publication number: 20040203062
    Abstract: The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and its use in diagnosis and therapy. This nucleic acid molecule (IIP-10) is a gene which encodes an IGF-1 receptor binding polypeptide.
    Type: Application
    Filed: May 12, 2004
    Publication date: October 14, 2004
    Inventors: Tanja Ligensa, Ralf Schumacher, Michael Weidner
  • IGF-1 receptor interacting proteins
    Publication number: 20020146728
    Abstract: The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and its use in diagnosis and therapy. This nucleic acid molecule (IIP-10) is a gene which encodes an IGF-1 receptor binding polypeptide.
    Type: Application
    Filed: October 30, 2001
    Publication date: October 10, 2002
    Inventors: Tanja Ligensa, Ralf Schumacher, Michael Weidner
  • IGF-1 receptor interacting proteins
    Publication number: 20020042389
    Abstract: The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and its use in diagnosis and therapy. This nucleic acid molecule (IIP-10) is a gene which encodes an IGF-1 receptor binding polypeptide.
    Type: Application
    Filed: July 30, 2001
    Publication date: April 11, 2002
    Inventors: Tanja Ligensa, Ralf Schumacher, Michael Weidner
  • IGF-1 receptor interacting proteins
    Patent number: 6368826
    Abstract: The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and its use in diagnosis and therapy. This nucleic acid molecule (IIP-10) is a gene which encodes an IGF-1 receptor binding polypeptide.
    Type: Grant
    Filed: December 2, 1999
    Date of Patent: April 9, 2002
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Tanja Ligensa, Ralf Schumacher, Michael Weidner